RDR03871

CAS No. 286008-51-3

RDR03871( RDR-03871 | RDR 03871 | ZINC20458540 )

Catalog No. M27921 CAS No. 286008-51-3

RDR03871 is an MDM2 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 153 In Stock
10MG 224 In Stock
25MG 337 In Stock
50MG 462 In Stock
100MG 631 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RDR03871
  • Note
    Research use only, not for human use.
  • Brief Description
    RDR03871 is an MDM2 inhibitor.
  • Description
    RDR03871 is an MDM2 inhibitor.(In Vitro):RDR03871 dissociated the MDM2/p53 with IC50 of 12.9nM in quantitative sandwich immune-enzymatic assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RDR-03871 | RDR 03871 | ZINC20458540
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    Nucleoside Antimetabolite/Analog
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    286008-51-3
  • Formula Weight
    408.81
  • Molecular Formula
    C18H16ClF3N6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1nc(nc(NCCNc2cccc(n2)C(F)(F)F)c1Cl)-c1ccccn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wipapat Kladwang, et al. Anomalous Reverse Transcription through Chemical Modifications in Polyadenosine Stretches. Biochemistry. 2020 Jun 16;59(23):2154-2170.
molnova catalog
related products
  • RETRA

    RETRA is a small molecule mutant p53 reactivator that activates a set of p53-regulated genes and specifically suppresses mutant p53-bearing tumor cells in vitro and in mouse xenograft.

  • MX69

    A novel specific inhibitor of MDM2 inhibitor with Kd of 2.75 uM.

  • PK-7088

    PK-7088 is a small molecule mutant p53 Y220C reactivator.